Gross Profit On Sales Alterar Data
AbbVie USD 9.56B 95M 2023-09
Acadia Pharmaceuticals USD 213.15M 16.07M 2023-12
ALKERMES USD 319.43M 234.71M 2023-09
Amgen USD 5.08B 14M 2023-12
Biogen USD 1.77B 102.7M 2023-12
BioMarin Pharmaceutical USD 510.73M 54.14M 2023-12
Bluebird Bio USD 1.44M 4.11M 2023-09
Bristol-Myers Squibb USD 8.77B 294M 2023-12
Eli Lilly USD 7.57B 73.1M 2023-12
Gilead Sciences USD 5.5B 18M 2023-12
Heron Therapeutics USD 13.23M 1.62M 2023-09
Intra Cellular Therapies USD 121.4M 4.35M 2023-12
Ionis Pharmaceuticals USD 321.44M 179.43M 2023-12
J&J USD 14.6B 374M 2023-12
Malin Corporation EUR 3.8M 2.6M 2020-12
Marinus Pharmaceuticals USD 6.88M 1.19M 2023-09
Merck USD 11.29B 441M 2023-12
Nektar Therapeutics USD 11.71M 1.79M 2023-09
Neurocrine Biosciences USD 487.6M 46.4M 2023-09
Otsuka Holdings JPY 374.05B 25.94B 2023-09
Pfizer USD 7.58B 3.26B 2023-12
Regeneron Pharmaceuticals USD 2.92B 9M 2023-12
Revance Therapeutics USD 37.36M 536K 2023-09
Vertex Pharmaceuticals USD 2.16B 19.8M 2023-09



ALKERMES Lucro Bruto Sobre Vendas - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Mar 2024.